Ulta Beauty, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ulta Beauty, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $12.39B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $11.30B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $11.21B | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $10.21B | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | $8.63B | Mar 26, 2024 |
| FY2020 | Jan 30, 2021 | $2.20B | Mar 26, 2021 |
| FY2020 | Oct 31, 2020 | $1.55B | Mar 26, 2021 |
| FY2020 | Aug 1, 2020 | $1.23B | Mar 26, 2021 |
| FY2020 | May 2, 2020 | $1.17B | Mar 26, 2021 |
| FY2020 | Feb 1, 2020 | $2.31B | Mar 26, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Feb 3, 2018 | $108.76M | Apr 3, 2018 |
| FY2017 | Oct 28, 2017 | $1.34B | Apr 3, 2018 |
| FY2017 | Jul 29, 2017 | $1.29B | Apr 3, 2018 |
| FY2017 | Apr 29, 2017 | $1.31B | Apr 3, 2018 |
| FY2017 | Jan 28, 2017 | $1.58B | Apr 3, 2018 |
| FY2017 | Oct 29, 2016 | $1.13B | Apr 3, 2018 |
| FY2017 | Jul 30, 2016 | $1.07B | Apr 3, 2018 |
| FY2017 | Apr 30, 2016 | $1.07B | Apr 3, 2018 |
| FY2016 | Jan 30, 2016 | $1.27B | Mar 28, 2017 |
| FY2016 | Oct 31, 2015 | $910.70M | Mar 28, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $4.85B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $4.39B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $4.38B | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $4.04B | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | $3.37B | Mar 26, 2024 |
| FY2020 | Jan 30, 2021 | $771.03M | Mar 26, 2021 |
| FY2020 | Oct 31, 2020 | $545.52M | Mar 26, 2021 |
| FY2020 | Aug 1, 2020 | $329.01M | Mar 26, 2021 |
| FY2020 | May 2, 2020 | $303.61M | Mar 26, 2021 |
| FY2020 | Feb 1, 2020 | $806.89M | Mar 26, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.15B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $1.20B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $1.29B | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $1.24B | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | $985.84M | Mar 26, 2024 |
| FY2020 | Jan 30, 2021 | $171.49M | Mar 26, 2021 |
| FY2020 | Oct 31, 2020 | $74.80M | Mar 26, 2021 |
| FY2020 | Aug 1, 2020 | $8.05M | Mar 26, 2021 |
| FY2020 | May 2, 2020 | ($78.51M) | Mar 26, 2021 |
| FY2020 | Feb 1, 2020 | $222.72M | Mar 26, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.53B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $1.56B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $1.68B | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $1.64B | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | $1.30B | Mar 26, 2024 |
| FY2020 | Jan 30, 2021 | $224.27M | Mar 26, 2021 |
| FY2020 | Oct 31, 2020 | $101.28M | Mar 26, 2021 |
| FY2020 | Aug 1, 2020 | $12.76M | Mar 26, 2021 |
| FY2020 | May 2, 2020 | ($101.48M) | Mar 26, 2021 |
| FY2020 | Feb 1, 2020 | $287.76M | Mar 26, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $3.30B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $2.81B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $2.69B | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $2.40B | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | $2.06B | Mar 26, 2024 |
| FY2020 | Jan 30, 2021 | $514.14M | Mar 26, 2021 |
| FY2020 | Oct 31, 2020 | $416.38M | Mar 26, 2021 |
| FY2020 | Aug 1, 2020 | $271.59M | Mar 26, 2021 |
| FY2020 | May 2, 2020 | $380.91M | Mar 26, 2021 |
| FY2020 | Feb 1, 2020 | $515.54M | Mar 26, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.50B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $1.34B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $1.48B | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $1.48B | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | $1.06B | Mar 26, 2024 |
| FY2022 | Jan 30, 2021 | $810.36M | Mar 24, 2023 |
| FY2021 | Feb 1, 2020 | $1.10B | Mar 25, 2022 |
| FY2020 | Feb 2, 2019 | $956.13M | Mar 26, 2021 |
| FY2019 | Feb 3, 2018 | $779.37M | Mar 27, 2020 |
| FY2018 | Jan 28, 2017 | $634.39M | Apr 2, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $434.83M | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $374.46M | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $435.27M | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $312.13M | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | $172.19M | Mar 26, 2024 |
| FY2022 | Jan 30, 2021 | $151.87M | Mar 24, 2023 |
| FY2021 | Feb 1, 2020 | $298.53M | Mar 25, 2022 |
| FY2020 | Feb 2, 2019 | $319.40M | Mar 26, 2021 |
| FY2019 | Feb 3, 2018 | $440.71M | Mar 27, 2020 |
| FY2018 | Jan 28, 2017 | $373.45M | Apr 2, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $7.00B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $6.00B | Mar 26, 2026 |
| FY2024 | Feb 3, 2024 | $5.71B | Mar 27, 2025 |
| FY2023 | Jan 28, 2023 | $5.37B | Mar 26, 2024 |
| FY2022 | Jan 29, 2022 | $4.76B | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $5.09B | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | $4.86B | Mar 26, 2021 |
| FY2019 | Feb 2, 2019 | $3.19B | Mar 27, 2020 |
| FY2018 | Feb 3, 2018 | $2.91B | Apr 2, 2019 |
| FY2017 | Jan 28, 2017 | $2.55B | Apr 3, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $4.20B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $3.51B | Mar 26, 2026 |
| FY2024 | Feb 3, 2024 | $3.43B | Mar 27, 2025 |
| FY2023 | Jan 28, 2023 | $3.41B | Mar 26, 2024 |
| FY2022 | Jan 29, 2022 | $3.23B | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $3.09B | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | $2.96B | Mar 26, 2021 |
| FY2019 | Feb 2, 2019 | $1.37B | Mar 27, 2020 |
| FY2018 | Feb 3, 2018 | $1.13B | Apr 2, 2019 |
| FY2017 | Jan 28, 2017 | $1.00B | Apr 3, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $2.80B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $2.49B | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $2.28B | Mar 26, 2026 |
| FY2025 | Jan 28, 2023 | $1.96B | Mar 26, 2026 |
| FY2024 | Jan 29, 2022 | $1.54B | Mar 27, 2025 |
| FY2023 | Jan 30, 2021 | $2.00B | Mar 26, 2024 |
| FY2022 | Feb 1, 2020 | $1.90B | Mar 24, 2023 |
| FY2021 | Feb 2, 2019 | $1.82B | Mar 25, 2022 |
| FY2020 | Feb 3, 2018 | $1.77B | Mar 26, 2021 |
| FY2019 | Jan 28, 2017 | $1.55B | Mar 27, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $226.42M | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $10.87M | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | $10.87M | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | $10.87M | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | $10.87M | Mar 26, 2024 |
| FY2022 | Jan 30, 2021 | $10.87M | Mar 24, 2023 |
| FY2021 | Feb 1, 2020 | $10.87M | Mar 25, 2022 |
| FY2025 | Feb 2, 2019 | $10.87M | Mar 26, 2026 |
| FY2019 | Feb 3, 2018 | $0 | Mar 27, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $1.74B | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $1.47B | Mar 26, 2026 |
| FY2024 | Feb 3, 2024 | $1.29B | Mar 27, 2025 |
| FY2023 | Jan 28, 2023 | $995.77M | Mar 26, 2024 |
| FY2022 | Jan 29, 2022 | $653.38M | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $1.19B | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | $1.13B | Mar 26, 2021 |
| FY2019 | Feb 3, 2019 | $1.10B | Mar 27, 2020 |
| FY2019 | Feb 2, 2019 | $1.11B | Mar 27, 2020 |
| FY2018 | Feb 3, 2018 | $1.09B | Apr 2, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $424.24M | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | $703.20M | Mar 26, 2026 |
| FY2024 | Feb 3, 2024 | $766.59M | Mar 27, 2025 |
| FY2023 | Jan 28, 2023 | $737.88M | Mar 26, 2024 |
| FY2022 | Jan 29, 2022 | $431.56M | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | $1.05B | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | $392.33M | Mar 26, 2021 |
| FY2019 | Feb 2, 2019 | $409.25M | Mar 27, 2020 |
| FY2018 | Feb 3, 2018 | $277.45M | Apr 2, 2019 |
| FY2017 | Jan 28, 2017 | $385.01M | Apr 3, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 25 | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | 25 | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | 26 | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | 24 | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | 18 | Mar 26, 2024 |
| FY2020 | Jan 30, 2021 | 3 | Mar 26, 2021 |
| FY2020 | Oct 31, 2020 | 1 | Mar 26, 2021 |
| FY2020 | Aug 1, 2020 | 0 | Mar 26, 2021 |
| FY2020 | May 2, 2020 | (1) | Mar 26, 2021 |
| FY2020 | Feb 1, 2020 | 3 | Mar 26, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 25 | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | 25 | Mar 26, 2026 |
| FY2025 | Feb 3, 2024 | 26 | Mar 26, 2026 |
| FY2024 | Jan 28, 2023 | 24 | Mar 27, 2025 |
| FY2023 | Jan 29, 2022 | 17 | Mar 26, 2024 |
| FY2020 | Jan 30, 2021 | 3 | Mar 26, 2021 |
| FY2020 | Oct 31, 2020 | 1 | Mar 26, 2021 |
| FY2020 | Aug 1, 2020 | 0 | Mar 26, 2021 |
| FY2020 | May 2, 2020 | (1) | Mar 26, 2021 |
| FY2020 | Feb 1, 2020 | 3 | Mar 26, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 44.17M | Mar 26, 2026 |
| FY2025 | Feb 1, 2025 | 45.97M | Mar 26, 2026 |
| FY2024 | Feb 3, 2024 | 48.32M | Mar 27, 2025 |
| FY2023 | Jan 28, 2023 | 50.36M | Mar 26, 2024 |
| FY2022 | Jan 29, 2022 | 52.31M | Mar 24, 2023 |
| FY2021 | Jan 30, 2021 | 56.26M | Mar 25, 2022 |
| FY2020 | Feb 1, 2020 | 56.61M | Mar 26, 2021 |
| FY2019 | Feb 2, 2019 | 58.58M | Mar 27, 2020 |
| FY2018 | Feb 3, 2018 | 60.82M | Apr 2, 2019 |
| FY2017 | Jan 28, 2017 | 62.13M | Apr 3, 2018 |